Neuroprotective effects of activated protein C on intrauterine inflammation-induced neonatal white matter injury are associated with the downregulation of fibrinogen-like protein 2/fibroleukin prothrombinase and the inhibition of pro-inflammatory cytokine expression

Jin,Sheng-Juan; Liu,Yan; Deng,Shi-Hua; Liao,Li-Hong; Lin,Tu-Lian; Ning,Qin; Luo,Xiao-Ping

doi:10.3892/ijmm.2015.2136

Neuroprotective effects of activated protein C on intrauterine inflammation-induced neonatal white matter injury are associated with the downregulation of fibrinogen-like protein 2/fibroleukin prothrombinase and the inhibition of pro-inflammatory cytokine expression

Authors:
- Sheng-Juan Jin
- Yan Liu
- Shi-Hua Deng
- Li-Hong Liao
- Tu-Lian Lin
- Qin Ning
- Xiao-Ping Luo
View Affiliations

Affiliations: Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China, Department of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China
Published online on: March 13, 2015 https://doi.org/10.3892/ijmm.2015.2136
Pages: 1199-1212
Copyright: © Jin et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Maternal intrauterine inflammation or infection is an important risk factor for neonatal cerebral white matter injury (WMI) and future neurological deficits. Activated protein C (APC), a natural anticoagulant, has been shown to exhibit anti-inflammatory, anti-apoptotic, profibrinolytic and cytoprotective activities. Recent studies have demonstrated that the novel prothrombinase, fibrinogen-like protein 2 (fgl2), contributes to the pathogenesis of a number of inflammatory diseases through the generation of fibrin. Thus, we hypothesized that APC may regulate coagulant and inflammatory processes and improve brain injury in an experimental rat model of intrauterine inflammation-induced WMI. The animal model was established by the administration of an intraperitoneal injection of lipopolysaccharide (LPS) to pregnant Sprague-Dawley rats on embryonic day (E)17 and E18. APC was administered intraperitoneally 30 min after the second LPS injection. The expression of fgl2 and the pro-inflammatory cytokines, tumor necrosis factor-α (TNF-α), interleukin (IL)-6 and IL-1β expression in the placentas and fetal brains was determined on E19. Nerve cell death, the brain water content and protease-activated receptor 1 (PAR1) and nuclear factor κB (NF-κB) p65 expression was detected in the fetal brains. WMI in the neonatal rat brains was evaluated by hematoxylin and eosin (H&E) staining and immunohistochemistry for myelin basic protein (MBP). The results revealed that APC markedly reduced the LPS-induced increase in fgl2 expression and fibrin deposition, as well as the production of the pro-inflammatory cytokines, TNF-α, IL-6 and IL-1β, in the placentas and fetal brains. In addition, APC attenuated cerebral apoptosis and brain edema, downregulated PAR1 and NF-κB p65 expression in the fetal brains, and improved hypomyelination and structural disturbances in the periventricular area of the neonatal rat brains. Our observations provide evidence that APC attenuates fetal neuroinflammation and the associated secondary WMI in the developing brain by inhibiting the expression of fgl2 and pro-inflammatory mediators, suggesting that APC may be a potential therapeutic approach for intrauterine inflammation-induced neonatal brain injury.

View Figures

View References

1	Deng W: Neurobiology of injury to the developing brain. Nat Rev Neurol. 6:328–336. 2010. View Article : Google Scholar : PubMed/NCBI
2	Volpe JJ: Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol. 8:110–124. 2009. View Article : Google Scholar :
3	Favrais G, van de Looij Y, Fleiss B, et al: Systemic inflammation disrupts the developmental program of white matter. Ann Neurol. 70:550–565. 2011. View Article : Google Scholar : PubMed/NCBI
4	Kuypers E, Ophelders D, Jellema RK, Kunzmann S, Gavilanes AW and Kramer BW: White matter injury following fetal inflammatory response syndrome induced by chorioamnionitis and fetal sepsis: lessons from experimental ovine models. Early Hum Dev. 88:931–936. 2012. View Article : Google Scholar : PubMed/NCBI
5	Leclerc J, Pu Q, Corseaux D, Haddad E, Decoene C, Bordet R, Six I, Jude B and Vallet B: A single endotoxin injection in the rabbit causes prolonged blood vessel dysfunction and a procoagulant state. Crit Care Med. 28:3672–3678. 2000. View Article : Google Scholar : PubMed/NCBI
6	Cai Z, Pan ZL, Pang Y, Evans OB and Rhodes PG: Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr Res. 47:64–72. 2000. View Article : Google Scholar : PubMed/NCBI
7	Yoon BH, Jun JK, Romero R, Park KH, Gomez R, Choi JH and Kim IO: Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1(beta), and tumor necrosis factor-(alpha)), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol. 177:19–26. 1997. View Article : Google Scholar : PubMed/NCBI
8	Lee J, Chan SL and Mattson MP: Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain. Neuromolecular Med. 2:29–45. 2002. View Article : Google Scholar : PubMed/NCBI
9	Cao Q, Li P, Lu J, Dheen ST, Kaur C and Ling EA: Nuclear factor NF-κB/p65 responds to changes in the Notch signaling pathway in murine BV-2 cells and in amoeboid microglia in postnatal rats treated with the γ-secretase complex blocker DAPT. J Neurosci Res. 88:2701–2714. 2010.PubMed/NCBI
10	Levy GA, Liu M, Ding J, Yuwaraj S, Leibowitz J, Marsden PA, Ning Q, Kovalinka A and Phillips MJ: Molecular and functional ana1ysis of the human prothrombinase gene (hfgl2) and its role in viral hepatitis. Am J Pathol. 156:1217–1225. 2000. View Article : Google Scholar : PubMed/NCBI
11	Chan CW, Chan MW, Liu M, Fung L, Cole EH, Leibowitz JL, Marsden PA, Clark DA and Levy GA: Kinetic analysis of a unique direct prothrombinase, fgl2, and identification of a serine residue critical for the prothrombinase activity. J Immunol. 168:5170–5177. 2002. View Article : Google Scholar : PubMed/NCBI
12	Phillippe M, Diamond AK, Sweet LM, Oppenheimer KH and Bradley DF: Expression of coagulation-related protein genes during LPS-induced preterm delivery in the pregnant mouse. Reprod Sci. 18:1071–1079. 2011. View Article : Google Scholar : PubMed/NCBI
13	Melnyk MC, Shalev I, Zhang J, et al: The prothrombinase activity of FGL2 contributes to the pathogenesis of experimental arthritis. Scand J Rheumatol. 40:269–278. 2011. View Article : Google Scholar : PubMed/NCBI
14	Ning Q, Sun Y, Han M, et al: Role of fibrinogen-like protein 2 prothrombinase/fibroleukin in experimental and human allograft rejection. J Immunol. 174:7403–7411. 2005. View Article : Google Scholar : PubMed/NCBI
15	Yu G, Sun Y, Foerster K, Manuel J, Molina H, Levy GA, Gorczynski RM and Clark DA: LPS-induced murine abortions require C5 but not C3, and are prevented by upregulating expression of the CD200 tolerance signaling molecule. Am J Reprod Immunol. 60:135–140. 2008. View Article : Google Scholar : PubMed/NCBI
16	Liu M, Mendicino M, Ning Q, et al: Cytokine-induced hepatic apoptosis is dependent on FGL2/fibroleukin: the role of Sp1/Sp3 and STAT1/PU.1 composite cis elements. J Immunol. 176:7028–7038. 2006. View Article : Google Scholar : PubMed/NCBI
17	Zlokovic BV and Griffin JH: Cytoprotective protein C pathways and implications for stroke and neurological disorders. Trends Neurosci. 34:198–209. 2011. View Article : Google Scholar : PubMed/NCBI
18	Deane R, LaRue B, Sagare AP, Castellino FJ, Zhong Z and Zlokovic BV: Endothelial protein C receptor-assisted transport of activated protein C across the mouse blood-brain barrier. J Cereb Blood Flow Metab. 29:25–33. 2009. View Article : Google Scholar
19	Li B, Yu D and Xu Z: Activated protein C inhibits amyloid β production via promoting expression of ADAM-10. Brain Res. 1545:35–44. 2014. View Article : Google Scholar
20	Wang Y, Zhao Z, Chow N, Rajput PS, Griffin JH, Lyden PD and Zlokovic BV: Activated protein C analog protects from ischemic stroke and extends the therapeutic window of tissue-type plasminogen activator in aged female mice and hypertensive rats. Stroke. 44:3529–3536. 2013. View Article : Google Scholar : PubMed/NCBI
21	Yesilirmak DC, Kumral A, Tugyan K, Cilaker S, Baskin H, Yilmaz O, Duman N and Ozkan H: Effects of activated protein C on neonatal hypoxic ischemic brain injury. Brain Res. 1210:56–62. 2008. View Article : Google Scholar : PubMed/NCBI
22	Yesilirmak DC, Kumral A, Baskin H, et al: Activated protein C reduces endotoxin-induced white matter injury in the developing rat brain. Brain Res. 1164:14–23. 2007. View Article : Google Scholar : PubMed/NCBI
23	Olivier P, Fontaine RH, Loron G, et al: Melatonin promotes oligodendroglial maturation of injured white matter in neonatal rats. PLoS One. 4:e71282009. View Article : Google Scholar : PubMed/NCBI
24	Bell MJ, Hallenbeck JM and Gallo V: Determining the fetal inflammatory response in an experimental model of intrauterine inflammation in rats. Pediatr Res. 56:541–546. 2004. View Article : Google Scholar : PubMed/NCBI
25	Zaretsky MV, Alexander JM, Byrd W and Bawdon RE: Transfer of inflammatory cytokines across the placenta. Obstet Gynecol. 103:546–550. 2004. View Article : Google Scholar : PubMed/NCBI
26	Jia P, Wang J, Wang L, et al: TNF-α upregulates fgl2 expression in rat myocardial ischemia/reperfusion injury. Microcirculation. 20:524–533. 2013. View Article : Google Scholar : PubMed/NCBI
27	Clark DA, Ding JW, Yu G, Levy GA and Gorczynski RM: Fgl2 prothrombinase expression in mouse trophoblast and decidua triggers abortion but may be countered by OX-2. Mol Hum Reprod. 7:185–194. 2001. View Article : Google Scholar : PubMed/NCBI
28	Leviton A and Dammann O: Coagulation, inflammation, and the risk of neonatal white matter damage. Pediatr Res. 55:541–545. 2004. View Article : Google Scholar : PubMed/NCBI
29	Rezaie AR: Regulation of the protein C anticoagulant and anti-inflammatory pathways. Curr Med Chem. 17:2059–2069. 2010. View Article : Google Scholar
30	Bell MJ and Hallenbeck JM: Effects of intrauterine inflammation on developing rat brain. J Neurosci Res. 70:570–579. 2002. View Article : Google Scholar : PubMed/NCBI
31	French HM, Reid M, Mamontov P, Simmons RA and Grinspan JB: Oxidative stress disrupts oligodendrocyte maturation. J Neurosci Res. 87:3076–3087. 2009. View Article : Google Scholar : PubMed/NCBI
32	Brehmer F, Bendix I, Prager S, et al: Interaction of inflammation and hyperoxia in a rat model of neonatal white matter damage. PLoS One. 7:e490232012. View Article : Google Scholar : PubMed/NCBI
33	Karperien A, Ahammer H and Jelinek HF: Quantitating the subtleties of microglial morphology with fractal analysis. Front Cell Neurosci. 7:32013. View Article : Google Scholar : PubMed/NCBI
34	Verney C, Pogledic I, Biran V, Adle-Biassette H, Fallet-Bianco C and Gressens P: Microglial reaction in axonal crossroads is a hallmark of noncystic periventricular white matter injury in very preterm infants. J Neuropathol Exp Neurol. 71:251–264. 2012. View Article : Google Scholar : PubMed/NCBI
35	Suo Z, Wu M, Ameenuddin S, Anderson HE and Zoloty JE: Participation of protease-activated receptor-1 in thrombin-induced microglial activation. J Neurochem. 80:655–666. 2002. View Article : Google Scholar : PubMed/NCBI
36	Yuan TM, Sun Y, Zhan CY and Yu HM: Intrauterine infection/inflammation and perinatal brain damage: role of glial cells and Toll-like receptor signaling. J Neuroimmunol. 229:16–25. 2010. View Article : Google Scholar : PubMed/NCBI
37	Gabre J, Chabasse C, Cao C, Mukhopadhyay S, Siefert S, Bi Y, Netzel-Arnett S, Sarkar R and Zhang L: Activated protein C accelerates venous thrombus resolution through heme oxygenase-1 induction. J Thromb Haemost. 12:93–102. 2014. View Article : Google Scholar :
38	Puig F, Fuster G, Adda M, Blanch L and Farre R: Barrier-protective effects of activated protein C in human alveolar epithelial cells. PLoS One. 8:e569652013. View Article : Google Scholar : PubMed/NCBI
39	Ishii S, Mochizuki T, Nagao T, Kudo S, Fujita A, Taniguchi K, Kondo S and Kiyoki M: Pharmacokinetics of human activated protein C. 2nd communication: tissue distribution study of a lyophilized purified human activated protein C after single or repeated intravenous administration in male mice and placental transfer and milk passage study after intravenous administration in pregnant and lactating mice. Arzneimittelforschung. 45:644–656. 1995.PubMed/NCBI
40	Crawley JT and Efthymiou M: Cytoprotective effect of activated protein C: specificity of PAR-1 signaling. J Thromb Haemost. 6:951–953. 2008. View Article : Google Scholar : PubMed/NCBI
41	Riewald M, Petrovan RJ, Donner A, Mueller BM and Ruf W: Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science. 296:1880–1882. 2002. View Article : Google Scholar : PubMed/NCBI
42	Cao C, Gao Y, Li Y, Antalis TM, Castellino FJ and Zhang L: The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b. J Clin Invest. 120:1971–1980. 2010. View Article : Google Scholar : PubMed/NCBI
43	Mosnier LO, Yang XV and Griffin JH: Activated protein C mutant with minimal anticoagulant activity, normal cytoprotective activity, and preservation of thrombin activatable fibrinolysis inhibitordependent cytoprotective functions. J Biol Chem. 282:33022–33033. 2007. View Article : Google Scholar : PubMed/NCBI